NDC 10530-319

NEXAVIR

Liver Derivative Complex

NEXAVIR is a Intramuscular; Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Nexco Pharma. The primary component is Pork Liver.

Product ID10530-319_9eede347-6a07-6efd-e053-2995a90a9d8d
NDC10530-319
Product TypeHuman Prescription Drug
Proprietary NameNEXAVIR
Generic NameLiver Derivative Complex
Dosage FormInjection
Route of AdministrationINTRAMUSCULAR; SUBCUTANEOUS
Marketing Start Date2020-02-19
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameNexco Pharma
Substance NamePORK LIVER
Active Ingredient Strength26 mg/mL
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 10530-319-07

20 mL in 1 VIAL, MULTI-DOSE (10530-319-07)
Marketing Start Date2020-02-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 10530-319-07 [10530031907]

NEXAVIR INJECTION
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2020-02-19

Drug Details

Active Ingredients

IngredientStrength
PORK LIVER25.5 mg/mL

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.